Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change of safety laboratory measures associated with MVA-SARS-2-S;Occurrence of serious adverse events (SAE) associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of unsolicited adverse events (AE) associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST

Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change from baseline of pulmonary function associated with MVA-SARS-2-ST;Change of safety laboratory measures associated with MVA-SARS-2-S;Occurrence of serious adverse events (SAE) associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of solicited systemic reactogenicity signs and symptoms associated with MVA-SARS-2-ST;Occurrence of unsolicited adverse events (AE) associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST;The nature, frequency and severity of adverse events associated with MVA-SARS-2-ST